HopeStage
Back to all studies
Not recruitingISRCTN35823260

Exploratory study to assess the cerebral bioavailability of Silexan® WS® 1265 standard softgel capsule and Silexan® WS® 1265 enteric-coated capsule using quantitative Electroencephalography (EEG) in healthy volunteers

Research studyAges 18+GermanyAnxiety
The study in practice

Understand this study

Who could participate?

This study is for healthy volunteers. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
Germany

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Dr. Willmar Schwabe GmbH & Co. KG (Germany)
Sponsor type
Individual investigator
Study type
Other
Intervention type
Other / unclear
Locations
Germany
Age range
Over 18 Years
Official registry ID
ISRCTN35823260
Official title
Show the full official title

Exploratory study to assess the cerebral bioavailability of Silexan® WS® 1265 standard softgel capsule and Silexan® WS® 1265 enteric-coated capsule using quantitative Electroencephalography (EEG) in healthy volunteers

Recruitment & locations

Not recruiting

Germany

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Dr. Willmar Schwabe GmbH & Co. KG (Germany).

Who can participate?

This study is for healthy volunteers. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies